ReviewMini reviews in medicinal chemistry2026
Phytochemical and Pharmacological Studies of
Review in Mini reviews in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The genus Campylospermum (Ochnaceae) comprises about 65 species, including several with a long ethnomedicinal history in tropical regions of the world. The present review compiles the information available in the literature (until January 2025) on ethnomedicinal recommendations, phytochemical profiles, and biological activities, and suggests future prospects for the therapeutic applications of Campylospermum species (CS). Previous work revealed that 66 compounds, belonging to diverse families of secondary metabolites such as flavonoids, alkaloids, nitrile glucosides, steroids, and others, have been isolated and characterized in the genus. The structures of these compounds were determined by analysing their mass spectrometric (MS) and spectroscopic data and by comparison with those previously reported in the literature. DFT analysis was used to establish the structural conformation of calanthumidole 52. Some pure compounds, as well as crude extracts of the CS, have shown antimicrobial, cytotoxic, antileishmanial, and antimalarial activities by using disc-diffusion/agar-dilution assays, brine shrimp assay, parasite lactate-dehydrogenase (pLDH) assay, and Alamar blue assay, respectively. CS appears to be a good reservoir of flavonoids (59.1%) like amentoflavone, which moderately inhibits the promastigote form of Leishmania infantum. CS is used in folk medicine as a laxative, purgative, analgesic, and aphrodisiac, as well as for the treatment of various diseases, including dysentery, toothache, diarrhea, rheumatism, gastric pain, gonorrhea, icterus, whitlow, and malaria. This review mainly reports the known isolated and characterized compounds from CS and their biological activities, providing a reference for researchers worldwide to undertake further investigation and evaluate other CS species as a source of new bioactive compounds.
Indexed as
Identifiers
42283187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.